Engineering bacteria for cancer immunotherapy

Jesse G Zalatan,Lorenzo Petrini,Roger Geiger

DOI: https://doi.org/10.1016/j.copbio.2023.103061

IF: 10.279

2024-02-01

Current Opinion in Biotechnology

Abstract:Bacterial therapeutics have emerged as promising delivery systems to target tumors. These engineered live therapeutics can be harnessed to modulate the tumor microenvironment or to deliver and selectively release therapeutic payloads to tumors. A major challenge is to deliver bacteria systemically without causing widespread inflammation, which is critical for the many tumors that are not accessible to direct intratumoral injection. We describe potential strategies to address this challenge, along with approaches for specific payload delivery and biocontainment to ensure safety. These strategies will pave the way for the development of cost-effective, widely applicable next-generation cancer therapeutics.

biotechnology & applied microbiology,biochemical research methods